|
|
| Hester Biosciences Limited |
|
Financials-Hester Biosciences Limited| Sector: Miscella - Others | | BSE:524669 | NSE:HESTERBIO | Bloomberg:HBIO@IN | Reuters:HEST.BO | | Market Lot: 1 | Face Value: 10 | ISIN Demat: INE782E01017 |
|
|
| |
| Financials (Standalone) |
|
|
|
|
../financials/latestHalf.php
| Latest Quarterly/Halfyearly |
|
| As On(Months) |
31-Dec-2020(3) |
31-Dec-2019(3) |
% Change |
| Sales of Products/Services |
528.18 |
433.92 |
21.72 |
| Other Operating Income |
0.00 |
0.00 |
-- |
| Other Income |
6.35 |
14.64 |
-56.63 |
| Total Income |
534.53 |
448.56 |
19.17 |
| Total Expenses |
-356.08 |
-342.44 |
3.98 |
| OPBDIT |
890.61 |
791.00 |
12.59 |
| Interest |
0.00 |
0.00 |
-- |
| Depreciation |
-24.36 |
-342.44 |
-92.89 |
| Exceptional & Extraordinary Items |
0.00 |
0.00 |
-- |
| Prior Period Adjustments |
0.00 |
0.00 |
-- |
| Provision for Tax |
-45.54 |
-28.83 |
57.96 |
| After Tax Profit |
132.91 |
77.29 |
71.96 |
| Equity Capital |
0.00 |
0.00 |
-- |
| Reserves |
0.00 |
0.00 |
-- |
| Notes to Accounts |
|
|
|
|
| As on( Months ) |
31-Mar-06(12) |
|
31-Mar-05(12) |
|
31-Mar-04(12) |
|
| Profit / Loss A/C |
Rs mn |
%OI |
Rs mn |
%OI |
Rs mn |
%OI |
| Net Sales |
200.84 |
99.95 |
162.30 |
99.82 |
76.71 |
99.95 |
| Operating Income (OI) |
200.94 |
100.00 |
162.59 |
100.00 |
76.75 |
100.00 |
| OPBDIT |
89.60 |
44.59 |
69.39 |
42.68 |
25.08 |
32.68 |
| OPBDT |
87.03 |
43.31 |
66.77 |
41.07 |
22.19 |
28.91 |
| OPBT |
83.49 |
41.55 |
63.58 |
39.10 |
19.40 |
25.28 |
| Non-Operating Income |
0.02 |
0.01 |
-0.12 |
-0.07 |
0.00 |
0.00 |
| Extraordinary/Prior Period |
-14.65 |
-7.29 |
-3.94 |
-2.42 |
-7.10 |
-9.26 |
| Tax |
24.42 |
12.15 |
20.09 |
12.36 |
1.62 |
2.11 |
| Profit after tax(PAT) |
44.45 |
22.12 |
39.43 |
24.25 |
10.68 |
13.92 |
| Cash Profit |
47.98 |
23.88 |
42.62 |
26.22 |
13.46 |
17.54 |
| Dividend-Equity |
5.56 |
2.77 |
4.23 |
2.60 |
0.00 |
0.00 |
|
| As on |
31-Mar-06 |
|
31-Mar-05 |
|
31-Mar-04 |
|
| Assets |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Gross Block |
69.95 |
31.24 |
65.77 |
39.30 |
57.83 |
59.54 |
| Net Block |
46.47 |
20.76 |
45.59 |
27.24 |
40.60 |
41.80 |
| Capital WIP |
23.24 |
10.38 |
0.00 |
0.00 |
0.00 |
0.00 |
| Investments |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Inventory |
27.47 |
12.27 |
20.23 |
12.09 |
8.41 |
8.66 |
| Receivables |
84.72 |
37.84 |
76.73 |
45.85 |
39.86 |
41.03 |
| Other Current Assets |
41.98 |
18.75 |
24.80 |
14.82 |
8.26 |
8.51 |
| Balance Sheet Total(BT) |
223.88 |
100.00 |
167.34 |
100.00 |
97.13 |
100.00 |
| Liabilities |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Equity Share Capital |
37.08 |
16.56 |
35.27 |
21.08 |
35.27 |
36.31 |
| Reserves |
98.62 |
44.05 |
36.09 |
21.56 |
8.48 |
8.73 |
| Total Debt |
16.91 |
7.55 |
30.17 |
18.03 |
31.07 |
31.99 |
| Creditors and Acceptances |
8.47 |
3.78 |
14.21 |
8.49 |
6.75 |
6.95 |
| Other current liab/prov. |
62.79 |
28.05 |
51.61 |
30.84 |
15.56 |
16.02 |
| Balance Sheet Total(BT) |
223.88 |
100.00 |
167.34 |
100.00 |
97.13 |
100.00 |
|
| As on |
31-Mar-06 |
31-Mar-05 |
31-Mar-04 |
| OPBIT/Prod.cap.empl.(%) |
66.53 |
65.20 |
29.80 |
| PBIT/Cap. Employed (%) |
55.22 |
61.20 |
20.31 |
| PAT/Networth (%) |
32.75 |
55.25 |
24.41 |
| Tax/PBT (%) |
35.46 |
33.76 |
13.17 |
| Total Debt/Networth (x) |
0.12 |
0.42 |
0.71 |
| Long Term Debt/Networth (x) |
0.09 |
0.00 |
0.00 |
| PBDIT/Finance Charges (x) |
29.14 |
24.95 |
6.21 |
| Current Ratio (x) |
2.16 |
1.85 |
2.53 |
| RM Inventory (days consumption) |
160.84 |
125.24 |
140.54 |
| FG inventory (days cost of sales) |
24.61 |
20.96 |
23.44 |
| Receivables (days gross sales) |
153.97 |
172.56 |
189.64 |
| Creditors (days cost of sales) |
27.78 |
55.64 |
47.67 |
| Op. curr. assets (days OI) |
280.00 |
273.00 |
253.00 |
|
|
Financials